130 related articles for article (PubMed ID: 15542000)
1. Beyond lymph node staging: molecular predictors of outcome in breast cancer.
Sheldon DG
Surg Oncol Clin N Am; 2005 Jan; 14(1):69-84, vi. PubMed ID: 15542000
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of breast axillary lymph node metastasis.
Cavalli LR
Expert Rev Mol Diagn; 2009 Jul; 9(5):441-54. PubMed ID: 19580429
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.
Tez M; Tez S
Cancer; 2005 Oct; 104(8):1779-80; author reply 1780. PubMed ID: 16104028
[No Abstract] [Full Text] [Related]
4. Sentinel node biopsy before neoadjuvant chemotherapy for determining axillary status and treatment prognosis in locally advanced breast cancer.
Cox CE; Cox JM; White LB; Stowell NG; Clark JD; Allred N; Meyers M; Dupont E; Furman B; Minton S
Ann Surg Oncol; 2006 Apr; 13(4):483-90. PubMed ID: 16523361
[TBL] [Abstract][Full Text] [Related]
5. HPV status in sentinel nodes might be a prognostic factor in cervical cancer.
Lee YS; Rhim CC; Lee HN; Lee KH; Park JS; Namkoong SE
Gynecol Oncol; 2007 May; 105(2):351-7. PubMed ID: 17275890
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three scoring systems predicting non sentinel node metastasis in breast cancer patients with a positive sentinel node biopsy.
Dauphine CE; Haukoos JS; Vargas MP; Isaac NM; Khalkhali I; Vargas HI
Ann Surg Oncol; 2007 Mar; 14(3):1014-9. PubMed ID: 17176986
[TBL] [Abstract][Full Text] [Related]
7. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
[TBL] [Abstract][Full Text] [Related]
8. [Detailed pathological examination of the sentinel lymph nodes in order to detect micrometastases: no clinical relevance in patients with breast cancer].
Meijnen P; Peterse JL; Nieweg OE; Rutgers EJ
Ned Tijdschr Geneeskd; 2004 Dec; 148(49):2428-32. PubMed ID: 15626306
[TBL] [Abstract][Full Text] [Related]
9. The evolution of lymph node assessment in breast cancer.
Quan ML; McCready D
J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
[TBL] [Abstract][Full Text] [Related]
10. Impact and outcomes of routine microstaging of sentinel lymph nodes in breast cancer: significance of the pN0(i+) and pN1mi categories.
Pugliese MS; Beatty JD; Tickman RJ; Allison KH; Atwood MK; Szymonifka J; Arthurs ZM; Huynh PP; Dawson JH
Ann Surg Oncol; 2009 Jan; 16(1):113-20. PubMed ID: 18949520
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of sentinel lymph node micrometastasis in breast cancer.
Patani N; Mokbel K
Breast Cancer Res Treat; 2009 Apr; 114(3):393-402. PubMed ID: 18425678
[TBL] [Abstract][Full Text] [Related]
12. Molecular analysis improves sensitivity of breast sentinel lymph node biopsy: results of a multi-institutional prospective cohort study.
Mikhitarian K; Martin RH; Mitas M; Mauldin PD; Palesch Y; Metcalf JS; Cole DJ; Gillanders WE;
Surgery; 2005 Sep; 138(3):474-81. PubMed ID: 16213901
[TBL] [Abstract][Full Text] [Related]
13. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node.
Wada N; Imoto S; Yamauchi C; Hasebe T; Ochiai A
Eur J Surg Oncol; 2006 Feb; 32(1):29-33. PubMed ID: 16269227
[TBL] [Abstract][Full Text] [Related]
14. Multimarker RT-PCR assay for the detection of minimal residual disease in sentinel lymph nodes of breast cancer patients.
Nissan A; Jager D; Roystacher M; Prus D; Peretz T; Eisenberg I; Freund HR; Scanlan M; Ritter G; Old LJ; Mitrani-Rosenbaum S
Br J Cancer; 2006 Mar; 94(5):681-5. PubMed ID: 16495929
[TBL] [Abstract][Full Text] [Related]
15. Current status of sentinel lymph node biopsy in early breast cancer.
Jatoi I
Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
[TBL] [Abstract][Full Text] [Related]
16. A decision tool for predicting sentinel node accuracy from breast tumor size and grade.
Coombs N; Chen W; Taylor R; Boyages J
Breast J; 2007; 13(6):593-8. PubMed ID: 17983402
[TBL] [Abstract][Full Text] [Related]
17. Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases.
Rutgers EJ
J Clin Oncol; 2008 Feb; 26(5):698-702. PubMed ID: 18258976
[TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
19. [The role of sentinel lymph node biopsy in breast cancer non-invading-duct].
Török K; Péley G; Mátrai Z; Bidlek M; Szabó E; Sinkovics I; Polgár C; Farkas E; Orosz Z; Köves I
Magy Seb; 2006 Jun; 59(3):173-8. PubMed ID: 16937792
[TBL] [Abstract][Full Text] [Related]
20. Detection of breast cancer metastasis in sentinel lymph nodes using intra-operative real time GeneSearch BLN Assay in the operating room: results of the Cardiff study.
Mansel RE; Goyal A; Douglas-Jones A; Woods V; Goyal S; Monypenny I; Sweetland H; Newcombe RG; Jasani B
Breast Cancer Res Treat; 2009 Jun; 115(3):595-600. PubMed ID: 18716862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
